US Patent Number

9,790,233

Publication Date

10-17-2017

Abstract

Compounds and methods of modulating 15-PGDH activity, modulating tissue prostaglandin levels, treating disease, diseases disorders, or conditions in which it is desired to modulate 15-PGDH activity and/or prostaglandin levels include 15-PGDH inhibitors and 15-PGDH activators described herein.

Assignees

Case Western Reserve University, Cleveland, OH (US), Board of Regents of the University of Texas System, Austin, TX (US), University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

14/395,021

Filing Date

04/16/2013

Share

COinS